Background. Postoperative atrial fibrillation (POAF) increases considerably the chances of morbidity and mortality after cardiac surgery. The objective of this study was to identify the major risk factors responsible for POAF after thoracic aortic surgery in order to define preventive measures.
(p < 0.0001), history of smoking (p < [ 0.020), hypertension (p [ 0.020), congestive heart failure (p < 0.0001), urgent operation (p [ 0.023), and concomitant with nonelective coronary artery bypass (p [ 0.022). Postoperative mortality and postoperative stroke were significantly increased in patients with POAF (p < 0.0001 in both cases). The odds ratios for the POAF risk factors were as follows: replacement of the ascending aorta, 1.67; aortic arch, 1.62; aortic root, 1.42; concomitant with valve operation, 1.35; age, 1.27; and urgent operation, 1.22.
Conclusions. Several risk factors contribute to the incidence of POAF after thoracic aortic surgery. We found that POAF significantly increased 30-day operative mortality (p < 0.0001). Our findings can be used to develop a risk stratification system for the prediction of POAF.
(Ann Thorac Surg 2015;99:103-8) Ó 2015 by The Society of Thoracic Surgeons A trial fibrillation (AF) is a common type of arrhythmia that is frequently encountered after cardiac surgery and is considered a transient phenomenon [1] . Recently, many studies have reported that postoperative atrial fibrillation (POAF) is associated with longer hospital stay and predicts greater postoperative mortality [2] . The incidence of POAF has increased continuously over the past decades, and this is believed to be due to the aging of the population undergoing heart surgery. However, the incidence of POAF reported in previous studies varies between 20% and 50%, depending on the variety of operation, definitions of POAF itself, and methods of detection [3] . The pathophysiology of POAF after heart surgery is not precisely known; however, various risk factors have been reported and many studies have evaluated the prophylactic effect of different pharmacologic or physical interventions [4] . Thoracic aortic surgery is one of the most challenging operations in cardiac surgery and several possible confounding aspects exist; therefore, POAF management is directly associated with improved operative outcome. This study is the first in the Japanese population to stratify the risks for the development of POAF after thoracic aortic surgery and our findings can be useful for improving the outcome of thoracic aortic surgery.
Material and Methods
The Japan Adult Cardiovascular Surgery Database (JACVSD) was created in 2000 with the aim of recording and estimating surgical outcomes after cardiovascular procedures in various centers across Japan. This study was approved by our Institutional Review Board, and informed consent to participate in this study was obtained from each patient. We obtained data from this database to analyze the factors contributing to the occurrence of POAF after thoracic aortic surgery. The cardiovascular division of JACVSD for adults currently captures clinical information from 244 hospitals (45% of all Japanese units performing cardiac surgery in 2008).
The data collection form contains 255 variables (definitions are available online at http://www.jacvsd.umin.jp), which are almost identical to those in the Society of Thoracic Surgeons (STS) National Database (definitions are available online at http://sts.org). The JACVSD has developed software for web-based data collection; the data manager of each participating hospital submits data electronically to the central office through this webbased data collection system. Although participation in the JACVSD is voluntary, completeness of data is a high priority. Accuracy of the submitted data is maintained through audits; these audits are carried out by administrative office members who pay monthly visits to the participating hospitals to validate the data against clinical records. Data were further validated by independently comparing the volume of cardiac surgery conducted at the hospitals participating in the JACVSD with that reported in the Japanese Association for Thoracic Surgery annual survey. We examined the data of all cardiovascular surgeries (aortic surgery patients with atrial fibrillation) performed between January 1, 2004, and December 31, 2008. First, those JACVSD records that had been obtained without patients' informed consent were excluded from this analysis. Records with missing age (or age that was out of range), sex, or 30-day status (see "Endpoints") were also excluded. After exclusion of incomplete data from the analysis, the population for this risk model analysis consisted of 12,260 cardiovascular patient data from 244 participating sites throughout Japan.
We identified new-onset of AF after thoracic aortic surgery (postoperative AF, POAF) as the primary study variable. Therefore, any patient with a history of preoperative AF was excluded from the POAF group. The JACVSD database contains records of the preoperative history of AF, which was obtained by chart reviews and patient interviews. The study defines POAF as the occurrence of POAF or atrial flutter requiring treatment (by administration of agents such as beta-blockers, calcium-channel blockers, amiodarone, anticoagulation, or by cardioversion) as STS database definition. If the patient did not have a history of AF or paroxysmal AF or atrial flutter and was in sinus rhythm preoperatively, and developed AF after the operation, such patients were classified in the POAF group.
Endpoints
The primary outcome measure of JACVSD was 30-day mortality, defined as death within 30 days of an operation regardless of the patient's geographic location. It also included death within 30 days of an operation even if the patient has been discharged from the hospital. The secondary outcome of the JACVSD was 30-day operative mortality, which includes any patient who died during the index hospitalization regardless of the length of hospital stay, and any patient who died after being discharged from the hospital, within 30 days of the operation, as defined in the STS National Database. Using the definition from a previous study [5] , major morbidity was defined as any of the following 5 postoperative in-hospital complications: stroke, reoperation for any reason, need for mechanical ventilation for more than 24 hours after the surgery, renal failure, or deep sternal wound infection [6] .
The primary outcome measure of this study was the presence of new onset of AF after operation. To better ascertain the risk factors of POAF we identified 34 covariates of long-term mortality risk, and harvested this information from the JACVSD database for use in a riskadjustment analysis using standard JACVSD definitions or each risk factor and outcome. The analyzed covariates included age, sex, race, left ventricular ejection fraction, history of myocardial infarction, congestive heart failure, New York Heart Association functional class, stroke, hypertension, diabetes mellitus, renal failure, dyslipidemia, smoking, chronic obstructive lung disease, peripheral vascular disease, recent creatinine level, dialysis status, elective or urgent surgery, and the presence of any valvular disorder or postoperative complications (such as myocardial infarction, stroke, and postoperative respiratory distress syndrome).
Statistical Analysis
We used bivariate tests to compare the differences between 2 groups; patients with new-onset AF and patients whose sinus rhythm was maintained after surgery. Fisher exact tests and c 2 tests were used for categoric covariates; namely, age, sex, body surface area, body mass index, and creatinine. Unpaired t tests and Wilcoxon rank sum tests were used for continuous covariates; namely, diabetes mellitus, renal failure, hypertension, chronic lung disease, dyslipidemia, cerebral vascular disease, smoking history, peripheral vascular disease, neurologic dysfunction, chronic obstructive pulmonary disease, dialysis, myocardial infarction, congestive heart disease, urgent operation, body mass index greater than 30, nonelective coronary artery bypass, aortic stenosis, aortic insufficiency, mitral insufficiency, and reoperation.
To develop risk models of atrial fibrillation we conducted multivariate stepwise logistic regression analysis for each outcome. The stability of the model was checked every time a variable was eliminated. When all the statistically nonsignificant variables (p < 0.1) had been eliminated from the model, we evaluated the "goodnessof-fit" and used the area under the receiver operating 
Results

Cohort Characteristics
The POAF occurred in 2,095 of the 12,260 (17.1%) patients. Table 1 presents the cohort characteristics of the patients in this study. The mean age (AE standard deviation) was 67.5 AE 12.7 years, and 27% of the patients were women. Table 2 presents 30-day mortality and 30-day operative mortality of the POAF patients. A total of 125 patients with POAF died within 30 days after thoracic aortic operation; however, there was no significant increase in mortality among POAF patients compared with that in no POAF patients (p ¼ 0.148). On the other hand, 211 patients with POAF died during index hospitalization, indicating that POAF significantly increased 30-day operative mortality in POAF patients compared with that in no POAF patients (p < 0.0001). According to the STS database definition, 30-day operative mortality includes any patient who died during the index hospitalization regardless of the length of hospital stay, and any patient who died after being discharged from the hospital, within 30 days of the operation. Thus, this may suggest that patients with POAF have longer hospitalization stay and significantly increased mortality. A total of 91 patients with POAF died after 30 days of hospitalization. Table 3 summarizes the percentage of occurrence of POAF in relation to the range of aortic replacement. Descending and thoracoabdominal aortic replacement usually do not require cardiac arrest; therefore, patients who undergo these surgeries were less likely to undergo POAF. Univariate analysis identified differences in the characteristics of patients with and without POAF. These variables are shown in Table 4 . The following risk factors (Table 5) were associated with increased POAF: age (p < 0.0001), history of smoking (p < 0.0001), hypertension (p ¼ 0.020), neurologic impairment (p < 0.0001), congestive heart failure (p < 0.0001), procedure urgency (p < 0.0001), and critical preoperative condition (p ¼ 0.001) concomitant with coronary surgery (p ¼ 0.001).
The incidence of postoperative stroke, postoperative prolonged ventilation, and postoperative pneumonia was also the same (p < 0.0001). Table 6 shows preoperative antiarrhythmic drugs among these patients. There was no significant difference between the no POAF and POAF groups with regard to preoperative antiarrhythmic drugs. We could not obtain any information about the prophylactic management in our study; moreover, we could not determine the optimum treatment approach for the individual cases of atrial fibrillation.
The odds ratios of the risk factors of POAF ( 
Survival Analysis
Some authors reported that POAF was associated with increase in the 30-day mortality and morbidity. However, as shown in Table 2 , our results revealed that there was no significant difference in 30-day mortality between POAF patients and no POAF patients (p ¼ 0.148). In contrast, we found a significant difference in 30-day operative mortality between these 2 groups of patients. This may indicate that POAF patients with prolonged hospitalization period are at increased risk of mortality.
Comment
Our analysis results revealed that the incidence of POAF after thoracic aortic surgery was 17.1%. Thoracic aortic surgery is one of the most challenging operations in the field of cardiac surgery; however, no previous reports have investigated the incidence of POAF after aortic surgery. Motomura and colleagues [5] reported that many factors contribute to the difficulty of thoracic aortic surgery; location of the lesion, patients' age, emergency procedure, respiratory function, etc. Previous studies have mostly referred to POAF in patients undergoing coronary artery bypass graft (CABG). Mariscalco and Engstr€ om [7] addressed new-onset POAF in a study of patients undergoing CABG at 2 Italian centers. They studied 1,832 patients undergoing isolated CABG and reported that POAF occurred in 31% of the study subjects and was associated with increased long-term mortality. However, in their analysis they did not exclude patients with history of paroxysmal AF. Because history of AF is associated with increased mortality in population studies and in patients with coronary artery disease, their reported association between POAF and mortality could have been biased by this effect. Our study excluded patients with paroxysmal AF or with history of AF. Aortic surgery is usually more invasive than CABG; however, our findings revealed that the onset of POAF after aortic surgery was nearly identical to the onset of POAF after CABG as reported in the previous study. The presence of POAF significantly increased the ventilation time and complications of pneumonia [3] . The incidence of postoperative prolonged ventilation and postoperative pneumonia was significantly increased in patients with POAF (p < 0.0001) ( Table 4 ). Echahidi and colleagues [3] reported that POAF was induced by the stress caused to the respiratory system. The underlying mechanisms involved in POAF development are multifactorial, and currently far from being fully elucidated. However, studies have proposed some causative mechanisms, including pericardial inflammation, excessive catecholamine production, autonomic imbalance during the postoperative period, and interstitial mobilization of fluid [8, 9] . These factors might alter atrial refractoriness and reduce atrial conduction. Multiple reentry wavelets resulting from the dispersion of atrial refractoriness seem to be the electrophysiologic mechanism of POAF [8, 9] . However, the reason for the inter-individual susceptibility to POAF remains to be understood. At least 1 possible explanation is that patients with a structural substrate before the operation, who are consequently prone to atrial electrical reentry, are more vulnerable to the physiologic perturbations encountered in the postoperative period [10] . Alternatively, this substrate could have been created as a result of the surgical procedure itself. It is indeed possible that physical alterations of the cardiac structure resulting from incision of the atria or perioperative ischemia might increase cardiac susceptibility to rhythm disturbances [2] . It is well known that neurohormonal activation increases susceptibility to POAF [11, 12] . Increased sympathetic and parasympathetic activation alter atrial refractoriness (eg, shortening of the atrial effective refractory period), thus possibly contributing to the arrhythmia substrate [13] . Hogue and colleagues [14] reported that patients developing POAF have either higher or lower RR interval variability, suggesting that increased sympathetic or vagal tone occurs before arrhythmia onset. These findings suggest that interventions that modulate both the sympathetic and parasympathetic nervous systems might be beneficial in suppressing this postoperative arrhythmia. An increasing body of evidence suggests that inflammation plays an important role in the pathogenesis of POAF. Two recent studies have shown that inflammation can alter atrial conduction, facilitating reentry and then predisposing to POAF development [15, 16] . It is well known that extracorporeal circulation is characterized by a systemic inflammatory response, which might in part be responsible for the occurrence of POAF [17, 18] . Interestingly, it has been recently reported that leukocytosis, which is usually encountered in the days after cardiopulmonary bypass, is an independent predictor for the occurrence of POAF. Obesity is associated with higher cardiac output requirement and larger left ventricular and left atrial sizes. These factors might predispose to the development of POAF [19] . Our study also reported that patients with higher body mass index had increased incidence of POAF (Table 3) . Unfortunately, currently available registries do not collect detailed information on postoperative management (based on American College of Cardiology/ American Heart Association/European Society of Cardiology and American College of Chest Physicians guidelines) of postoperative AF and its impact on survival [20] . Likewise, data on optimal prophylaxis and, more importantly, on its effectiveness in preventing new-onset postoperative AF are lacking. Many authors have demonstrated that POAF increased the 30-day mortality and morbidity. Our study revealed that POAF patients had higher 30-day operative mortality than no POAF patients. Based on the STS database definition for 30-day operative mortality, we consider that patients with POAF are more likely to have prolonged hospital stay and an increased risk of mortality. We also reported that POAF patients had significantly increased incidence of postoperative stroke; however, we cannot establish a direct relationship between these factors as we did not analyze patients with postoperative stroke who had new onset of AF or patients with POAF who presented with stroke. Nevertheless, POAF patients had more morbidity and showed a higher mortality risk. Therefore, more careful attention should be given to treat patients with POAF.
Study Limitations
This study has several limitations. First, although the analyzed data were obtained from 244 hospitals all over Japan, the cases cannot be assumed to be representative of all Japanese cases. Second, these 244 hospitals were relatively high-volume centers in comparison with many Japanese hospitals, which might have affected our result even if the data were not particularly large. Third, we did not divide our data into analysis and validation datasets because of the relatively small volume of our data. Furthermore, the JACVSD database defines AF among different pharmacologic treatments or physical interventions preoperatively and postoperatively. We have excluded the patients with a history of paroxysmal or permanent AF because the JACVSD database only collected preoperative history of AF within 2 weeks of surgery. Thus, there may be a risk that the data used for the analysis were inaccurate, especially for patients with no symptom of paroxysmal AF or intermittent AF.
Conclusions
We have reported the first study in the Japanese population on POAF after thoracic aortic surgery that uses a nationwide cardiovascular surgery database. In conclusion, the incidence of new onset of POAF after thoracic aortic surgery was 17.1%. By analyzing 12,660 procedures from 244 hospitals throughout Japan, we found that patients with POAF after thoracic aortic surgery showed 30-day mortality and 30-day operative mortality rates of 6.0% and 10.1%, respectively. The results may suggest that good control of POAF results in good outcome of thoracic aortic surgery.
